Kara Kelly

Nov 20, 2023 | brnw.ch | Kara Kelly |Jonathan W. Friedberg

SUPPORTSupported in part by National Cancer Institute (R01CA262265). Conception and design: All authorsCollection and assembly of data: All authorsData analysis and interpretation: All authorsManuscript writing: All authorsFinal approval of manuscript: All authorsAccountable for all aspects of the work: All authorsClassic Hodgkin Lymphoma in Adolescents and Young AdultsThe following represents disclosure information provided by authors of this manuscript.

Nov 20, 2023 | ascopubs.org | Kara Kelly

Hodgkin lymphoma (HL) represents one of the more common cancers occurring in adolescent and young adults (AYAs) age 15-39 years. Despite a generally high cure rate, age-related differences in HL biology and the optimal therapeutic approaches including supportive care and risks for long-term adverse effects in the AYA population remain understudied. After an overview of HL epidemiology and biology in the AYA population, this review will cover frontline pediatric and adult treatment approaches.